Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.22 (
cdc2
)
8,319
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Meiotic maturation in oocytes is a prolonged process that is unique because of cell cycle arrests at prophase of meiosis I (MI) and at metaphase of meiosis II (MII). Fluctuations in cyclin-dependent kinase 1 (CDK1/CDC2A) activity govern meiotic progression, yet little is known about how these fluctuations are achieved. CDC14 is a highly conserved dual-specificity phosphatase that counteracts the function of proteins phosphorylated by
CDK
. Mammals contain two CDC14 homologs, CDC14A and
CDC14B
. We report that
CDC14B
localizes with the meiotic spindle in mouse oocytes, and (unlike somatic cells) it does not localize in the nucleolus. Oocytes that overexpress
CDC14B
are significantly delayed in resuming meiosis and fail to progress to MII, whereas oocytes depleted of
CDC14B
spontaneously resume meiosis under conditions that normally inhibit meiotic resumption. Depletion of FZR1 (CDH1), a regulatory subunit of the anaphase-promoting complex/cyclosome that targets cyclin B1 (CCNB1) for ubiquitin-mediated proteolysis, partially restores normal timing of meiotic resumption in oocytes with excess
CDC14B
. These studies also reveal that experimentally altering
CDC14B
levels generates eggs with abnormal spindles and with chromosome alignment perturbations. Our data indicate that
CDC14B
is a negative regulator of meiotic resumption and may regulate MI in mouse oocytes.
...
PMID:CDC14B acts through FZR1 (CDH1) to prevent meiotic maturation of mouse oocytes. 1912 9